Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2022-12-22 00:00:00 ET · period of report 2022-12-21 · accession 0001493152-22-036367 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-22 | 2022-12-21 | IMDX | Ross Douglas T. | Former CSO | A - Grant | $0.00 | +213.8K | 234.1K | +1,052% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2022-12-21 | A | A | 213,797 | $0.00 | 234,114 | D | — | — | (F1) The restricted stock units will vest as follows: (i) one-third on January 31, 2023, (ii) one-third on February 28, 2023, and (ii) one-third on March 31, 2023 (each such date, a "Vesting Date"), in each case, subject to the Reporting Person's continuous service as a consultant on each applicable Vesting Date. |